Showing results (1701-1710 of 9,979) with videos related to

Sort By:
Pageof 998
Leukemia & Lymphoma|October 17, 2018
Italian expert panel consensus statement on the optimal use of PD-1 blockade therapy in classical Hodgkin lymphomaPier Luigi Zinzani, Armando Santoro, Arturo Chiti, et al.
Leukemia & Lymphoma|October 3, 2018
Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinibJacqueline C Barrientos, Jan A Burger, John C Byrd, et al.
Leukemia & Lymphoma|October 3, 2018
The JAK inhibitor antcin H exhibits direct anticancer activity while enhancing chemotherapy against LMP1-expressed lymphomaYu-Fon Chen, Chien-Hsiang Chang, Zih-Ning Huang, et al.
Leukemia & Lymphoma|October 3, 2018
The size and depth of lesions measured by endoscopic ultrasonography are novel prognostic factors of primary gastric diffuse large B-cell lymphomaYi-Zhen Liu, Kai Xue, Bo-Shi Wang, et al.
Leukemia & Lymphoma|October 3, 2018
Efficacy of salvage chemotherapy in diffuse large B cell lymphoma with primary treatment failure according to putative cell of originTalha Badar, Mehdi Hamadani, Veronika Bachanova, et al.
Leukemia & Lymphoma|October 3, 2018
Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patientsKevin C Miller, Aref Al-Kali, Mithun V Shah, et al.
Leukemia & Lymphoma|October 11, 2018
Clinical and biological characteristics of acute myeloid leukemia with 20-29% blasts: a retrospective single-center studyChen Mei, Yanling Ren, Xinping Zhou, et al.
Leukemia & Lymphoma|October 11, 2018
Classical pediatric Hodgkin lymphoma in very young patients: the Italian experiencePiero Farruggia, Giuseppe Puccio, Francesco Locatelli, et al.
Leukemia & Lymphoma|June 24, 2017
Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemiaJose D Sandoval-Sus, Julio C Chavez, Samir Dalia, et al.
Leukemia & Lymphoma|July 7, 2017
Evaluation of the cytotoxic response mediated by perforin and granzyme B in patients with non-Hodgkin lymphomaBruna Maria Bereta Souza, Fernanda Bernadelli De Vito, Marianna Licati Calado, et al.
Pageof 998